Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label, Comparative Clinical Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

NCT07119372 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT07119372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07119372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label, Comparative Clinical Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Lead sponsor
Biocad
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 1, 2025
Completion date
October 31, 2027
Enrollment
228 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic kidney disease, chronic kidney disease 5d, chronic kidney disease patients on hemodialysis